This is all great news, even if it is second or third hand. There is no doubt that Don and Resverlogix are gaining momentum with all the talk and attention being give to epigenitices of late. I said this a while ago and still think that Zenith is the golden goose in all of this. It is quite possible that the sale of a couple of Zenith's compounds would bring enough to cover Revserlogix's debt and bring all the intelectual property back into Zenith's fold. This is speculation but that would give Don a tidy little package to market with Rvx208 (apabetalone) Sounds good but he also requires cash to continue these multi trials that are underway. So you sell some Zenith shares to Dart for a tide sum which I am sure he would be willing to do, I do not think Dart has any claim to Zenith. Please correct me if I am wrong. There are so many options for Don, any one could eliminate the debt issue which is what I think is holding down the PPS of Resverlogix. Just my opinion. Do your own DD.